Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
On this week's Medtech Insight podcast: the response by a US FDA advisory panel to Claret Medical's de novo submission for the first brain-filter device intended to protect patients undergoing transcatheter aortic heart-valve replacement; a reporting trip to the Israeli innovation hub; a Boston Scientific recall; and bariatric surgery data.
On this week's Medtech Insight podcast: US House Ways and Means Committee sets out plans for the next two years, including a review of all taxes and fees connected to the Affordable Care Act; Allergan and Hologic enter into separate big-money acquisitions in the aesthetics devices arena; a deep-dive look at the osteoporosis diagnostics market.
On this week's Medtech Insight podcast: congressional efforts to permanently repeal the medical device tax; a coordinated registry network for stroke devices; a GAO report on US FDA's Medical Device Reporting system related to power morcellators; January’s FDA approval trends.
On this week's Medtech Insight podcast: industry response to signals and policies from the Trump administration; US Supreme Court justice nominee Judge Neil Gorsuch has ties to a 2015 preemption case involving Medtronic; legal experts predict an uptick in false-claims cases; details on a new Meddevicetracker report on cardiac rhythm management.
On this week's Medtech Insight podcast: Executive orders signed by President Trump during his first week in office impacted the device industry, from hiring freezes at US FDA, to fallout from the beginning stages of ACA repeal, to industry concern over the scrapping of the Trans-Pacific Partnership.
A big JP Morgan meeting in San Francisco, possible repeal of the Obamacare medical device tax, a record-breaking False Claims Act settlement, and a new combination products guidance were the topics of this week's Medtech Insight podcast.
On this week's podcast, we discuss the latest medical device tax repeal bill, US FDA's approach to device accessories, Medicare bundled-payment programs and response from industry, and the closing of the major Abbott-St. Jude Medical acquisition.
On this week’s podcast, David Filmore and Tina Tan discuss the MTI 100, Medtech Insight’s annual analysis of revenue leaders in the medtech space.
On this week's podcast, we discussed the 21st Century Cures Act, which is headed towards likely enactment this year and includes an array of reforms to streamline the FDA process for medtech. Also, the Trump transition team’s picks for HHS and CMS. Finally, we talked about Edwards Lifesciences' recent acquisition of Valtech Cardio and key imaging industry product launches announced at this year's RSNA meeting.
You must sign in to use this functionality.
Please Sign In
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with active subscriptions will be able to access the full article. All other readers will be directed to the abstract and may purchase the article.